Home / Inspections / 1091217

FDA Inspection 1091217 — Mylan Laboratories Limited (FDF-2)

Mylan Laboratories Limited (FDF-2) — FEI 3008316970

The FDA completed an inspection of Mylan Laboratories Limited (FDF-2) on April 26, 2019 in Chhatrapati Sambhajinagar. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 26, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chhatrapati Sambhajinagar (India)

Facility

Other inspections at this facility

  • 1253435 (VAI Fri Feb 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1122884 (NAI Fri Feb 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1012796 (VAI Fri May 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 884211 (NAI Fri May 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 775616 (VAI Fri Mar 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources